Study to Evaluate the Efficacy, Safety, and Tolerability of Luvadaxistat in Participants With Cognitive Impairment Associated With Schizophrenia
Clinical trial NCT05182476 · TERMINATED
Trial details
- NCT number
- NCT05182476
- Sponsor
- Neurocrine Biosciences
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-07
- Primary completion
- 2024-06-28
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.